EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease

Published on 16 Dec 2024 on Zacks · via Yahoo Finance

The CHMP's opinion is based on late-stage data, which show that LLY's Omvoh is effective in Crohn's...

Read the rest of the article

Start tracking your investments with Statfolio

Discover how the ISS National Lab sponsored over 100 payloads in 2024, advancing R&D in areas lik...

Inferse.com 20 Dec 2024

Upon placement of a drug under the FDA’s shortage list, compounding pharmacies are allowed to...

Zacks · via Yahoo Finance 20 Dec 2024

We recently compiled a list of the 6 Stocks Jim Cramer Talked About This Week. In this article, w...

Insider Monkey · via Yahoo Finance 19 Dec 2024

The Village of Pleasant Prairie Plan Commission on Monday approved the preliminary site and...

Kenosha News 18 Dec 2024

The CHMP's opinion is based on late-stage data, which show that LLY's Omvoh is effective in Crohn...

Zacks · via Yahoo Finance 16 Dec 2024

The name brand, Cymbalta, is manufactured by Eli Lilly and Company, which launched the drug to th...

USA TODAY · via Yahoo News 13 Dec 2024

We recently compiled a list of the 16 Best Income Stocks To Buy According to Analysts. In this...

Insider Monkey · via Yahoo Finance 13 Dec 2024

Eli Lilly and Company LLY announced that its board of directors approved a new $15 billion share...

Zacks · via Yahoo Finance 10 Dec 2024

Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is w...

Zacks · via Yahoo Finance 10 Dec 2024

Eli Lilly and Company LLY has announced a significant $15 billion share repurchase program. This ...

Benzinga 10 Dec 2024